Abstract:Calcium signal plays an important role in a variety of cancer cell metabolism, but knowledge on its role in head and neck squamous cell carcinoma (HNSCC) is limited. Store-operated calcium entry (SOCE) is the principal Ca2+ entry mechanism that maintains calcium concentration and produces calcium signal in non-excitable cells. SOCE is triggered by stromal interaction molecule 1 (STIM1), which is located in endoplasmic reticulum (ER) as Ca2+ sensor. Although, many studies demonstrated that STIM1 and SOCE play important functions in the regulation of many cancer progressions, their clinical relevance in HNSCC remains unclear. In this study, STIM1 expression levels notably increased in 89% HNSCC tissues compared with those in adjacent normal tissues. Meanwhile, this overexpression was close associated with tumor size but not with neck lymph node metastasis. Thus, this study mainly focuses on STIM1 function in HNSCC tumor growth. Three HNSCC cell lines, namely, TSCCA (oral cancer cell line) and Hep2 (laryngeal cell line) with high STIM1 expression levels and Tb3.1 (oral cancer cell line) with STIM1 expression level lower than previous two cell lines, were selected for in vitro study. Downregulated STIM1 expression levels in TSCCA and Hep2 arrested cells in G0/G1 stages, promoted cell apoptosis, and inhibited cell proliferation. By contrast, upregulated STIM1 expression in Tb3.1 inhibited cell apoptosis and promoted cell proliferation. Induced by thapsigargin (TG), ER stress was amplified when STIM1 expression was downregulated but was attenuated as STIM1 expression was upregulated. Furthermore, TSCCA cell xenograft models confirmed that STIM1 could promote HNSCC tumor growth in vivo. The present study provides new insight into HNSCC molecular mechanism and potential therapeutic target through targeting SOCE-dependent process. However, whether STIM1 participates in HNSCC metastasis requires further study.

Development of Store-Operated Calcium Entry-Targeted Compounds in Cancer

SOCE and Cancer: Recent Progress and New Perspectives

SOCE and cancer: Recent progress and new perspectives.

Store-operated Ca2+ Entry As a Key Oncogenic Ca2+ Signaling Driving Tumor Invasion-Metastasis Cascade and Its Translational Potential.

Spatiotemporal regulation of store-operated calcium entry in cancer metastasis

Store-operated Ca 2+ Entry Regulates Glioma Cell Migration and Invasion Via Modulation of Pyk2 Phosphorylation

Vulnerability of Store-Operated Calcium Entry to Inhibitors and Microenvironment in Cells of Different Breast Cancer Subtypes

Fluorescence-Based Measurements of Store-Operated Ca 2+ Entry in Cancer Cells Using Fluo-4 and Confocal Live-Cell Imaging.

Targeting calcium signaling in cancer therapy

Inhibition of Macropinocytosis Enhances the Sensitivity of Osteosarcoma Cells to Benzethonium Chloride.

Development and therapeutic implications of small molecular inhibitors that target calcium ion-related channels in tumor treatment

Connecting Calcium-Based Nanomaterials and Cancer: from Diagnosis to Therapy

STIM1 Expression is Associated with Osteosarcoma Cell Survival

Proton-sensing ion channels, GPCRs and calcium signaling regulated by them: implications for cancer

Store-Operated Calcium Channels in the Nervous System

Imaging Elemental Events of Store-Operated Ca2+ Entry in Invading Cancer Cells with Plasmalemmal Targeted Sensors

Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications

The L‐type calcium channel CaV1.3: A potential target for cancer therapy

Blocking of Stromal Interaction Molecule 1 Expression Influence Cell Proliferation and Promote Cell Apoptosis in Vitro and Inhibit Tumor Growth in Vivo in Head and Neck Squamous Cell Carcinoma

Amplifying Ca2+ overload by engineered biomaterials for synergistic cancer therapy

Calcium-based Nanotechnology for Cancer Therapy